Si P. Shi
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
Multi-label dynamic diagnosis of pancreatic diseases using AI-enhanced endoscopic ultrasound: a multi-cohort real-world study.
Journal: Surgical endoscopy
Published: March 02, 2026
The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy.
Journal: Oncogenesis
Published: January 15, 2026
Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 01, 2025
Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential.
Journal: Biomarker research
Published: October 17, 2025
Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer.
Journal: Cancer cell
Published: September 16, 2025
NLRP4 drives olaparib resistance in pancreatic cancer.
Journal: Autophagy reports
Published: May 21, 2025
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer.
Journal: Cell reports. Medicine
Published: April 17, 2025
Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma.
Journal: BMC medicine
Published: April 14, 2025
ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer.
Journal: Gastroenterology
Published: March 27, 2025
Last Updated: 09/26/2026